Revised SOPs for Aerosols V 2.0

This Standard Operating Procedure (SOP) defines the process for the formulation development of aerosol products. It ensures that the formulation of aerosol products is done in a controlled, compliant, and reproducible manner to achieve the desired product performance, quality, and regulatory compliance. This SOP outlines the key steps involved in the formulation development process, from initial concept through testing and optimization.
Click to read the full article.

This Standard Operating Procedure (SOP) outlines the procedure for selecting propellants for aerosol dosage forms. It ensures that the appropriate propellant is chosen based on the product’s requirements, such as efficacy, safety, stability, and regulatory compliance. The selection process considers factors such as solubility, pressure, compatibility with the formulation, and environmental impact, ensuring the chosen propellant meets all necessary criteria for the product’s performance.
Click to read the full article.

This Standard Operating Procedure (SOP) describes the process for developing analytical methods for aerosol products. It provides guidelines for selecting, developing, validating, and implementing analytical techniques to assess the quality and performance of aerosol formulations in accordance with Good Manufacturing Practices (GMP) and regulatory standards.
Click to read the full article.

This Standard Operating Procedure (SOP) outlines the process for conducting stability testing during the development of aerosol products. It ensures that aerosol formulations maintain their desired quality attributes, such as efficacy, appearance, and performance, under various environmental conditions over time. Stability testing helps to establish product shelf life, define storage conditions, and ensure regulatory compliance.
Click to read the full article.

This Standard Operating Procedure (SOP) describes the process for conducting compatibility studies of components used in aerosol formulations. The aim is to evaluate the chemical, physical, and functional compatibility of ingredients, including propellants, active ingredients, solvents, excipients, and packaging components, to ensure that no adverse interactions occur during the formulation, storage, or use of aerosol products. Compatibility studies help ensure product stability, efficacy, and safety.
Click to read the full article.

This Standard Operating Procedure (SOP) provides detailed instructions for designing pilot-scale batches for aerosol products. The goal is to ensure that the formulation and manufacturing process are optimized before full-scale production. Pilot-scale batches are designed to evaluate the scalability, stability, and performance of aerosol formulations under conditions that closely mimic commercial production.
Click to read the full article.

This Standard Operating Procedure (SOP) outlines the process for conducting particle size analysis in aerosol formulations. The purpose is to ensure that the particle size distribution of the aerosol product is within specified limits to provide consistent performance, optimal spray characteristics, and drug delivery (if applicable). This SOP covers the methods used for measuring particle size and evaluating the results in accordance with regulatory requirements and industry standards.
Click to read the full article.

This Standard Operating Procedure (SOP) outlines the process for testing the compatibility of valves and actuators used in aerosol formulations. The purpose of this testing is to ensure that the selected valve and actuator systems function effectively with the formulation, providing proper spray delivery and preventing issues such as leakage, clogging, or degradation of the packaging components. Compatibility testing is essential for ensuring the overall quality and safety of the aerosol product.
Click to read the full article.

This Standard Operating Procedure (SOP) outlines the process for conducting risk assessment during the product development phase of aerosol products. The purpose of this risk assessment is to identify, evaluate, and mitigate potential risks associated with the product’s formulation, manufacturing process, packaging, and usage. The goal is to ensure product safety, quality, and regulatory compliance, while also minimizing the likelihood of failures or safety concerns during the product lifecycle.
Click to read the full article.

This Standard Operating Procedure (SOP) outlines the requirements for documenting development batch records for aerosol products. Proper documentation is crucial for ensuring product consistency, traceability, and regulatory compliance. The batch records document all formulation and manufacturing steps, including raw materials, equipment used, in-process testing, and final product specifications.
Click to read the full article.